Evidence map›Paper›PMID 37860742›Full record

ReviewFood science and biotechnology2023

Non-digestible oligosaccharides-based prebiotics to ameliorate obesity: Overview of experimental evidence and future perspectives.

G Divyashri, Pothiyappan Karthik, T P Krishna Murthy, Dey Priyadarshini, Kakarla Raghava Reddy, Anjanapura V Raghu, Vinoth Kumar Vaidyanathan

Open access · greenAbstract readReview
In one paragraph

Review in Food science and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Bioactive Polysaccharides fromFoods (Basel, Switzerland) · 2024
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

G DivyashriDepartment of Biotechnology, M S Ramaiah Institute of Technology, Bengaluru, 560 054 India.
Pothiyappan KarthikDepartment of Food Technology, Faculty of Engineering, Karpagam Academy of Higher Education, Coimbatore, 641 021 India.
T P Krishna MurthyDepartment of Biotechnology, M S Ramaiah Institute of Technology, Bengaluru, 560 054 India.
Dey PriyadarshiniDepartment of Biotechnology, M S Ramaiah Institute of Technology, Bengaluru, 560 054 India.
Kakarla Raghava ReddySchool of Chemical and Biomolecular Engineering, The University of Sydney, Sydney, NSW 2006 Australia.
Anjanapura V RaghuFaculty of Allied Health Sciences, BLDE (Deemed-to-Be University), Vijayapura, 586103 Karnataka India.
Vinoth Kumar VaidyanathanDepartment of Biotechnology, School of Bioengineering, Integrated Bioprocessing Laboratory, SRM Institute of Science and Technology (SRM IST), 603 203 Kattankulathur, India.
M S Ramaiah University of Applied Sciences · INBLDE University · INKarpagam Academy of Higher Education · INSRM Institute of Science and Technology · INUniversity of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The diverse populations reportedly suffer from obesity on a global scale, and inconclusive evidence has indicated that both environmental and genetic factors are associated with obesity development. Therefore, a need exists to examine potential therapeutic or prophylactic molecules for obesity treatment. Prebiotics with non-digestible oligosaccharides (NDOs) have the potential to treat obesity. A limited number of prebiotic NDOs have demonstrated their ability as a convincing therapeutic solution to encounter obesity through various mechanisms, viz

Indexed as

Beneficial microorganismsLipid metabolism and Glucose homeostasisNon-digestible oligosaccharidesObesityPrebiotics

Identifiers

PMID37860742
PMCPMC10581984
OpenAlexW4385704179

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.